Organization
Saitama Cancer Center
8 abstracts
Abstract
Acquired gene alteration patterns and post-progression survival: PARADIGM study analysis.Org: National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan, Disaster Medical Center, Tokyo, Japan, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center Hospital East, Kashiwa, Japan,
Abstract
Tumor microenvironment-mediated immune profiles and efficacy of platinum doublet chemotherapy plus ICIs stratified by DLL3 expression in small cell lung cancer.Org: National Cancer Center Hospital East, Kashiwa, Japan, Division of Genome Biology, National Cancer Center Research Institute, Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, Department of Respiratory Medicine, NHO Iwakuni Clinical Center, Iwakuni, Japan,
Abstract
A confirmatory trial of modified radical hysterectomy for patients with FIGO stage IB1 cervical cancer with tumor diameter preoperatively estimated at 2 cm or less: Japan Clinical Oncology Group study, JCOG1101.Org: Toranomon Hospital, Tokyo Metropolitan Bokutoh Hospital, Radiation Therapy Center, Okinawa Chubu Hospital, Kagoshima University Hospital,
Abstract
Neoadjuvant chemotherapy (NAC) followed by total mesorectal excision (TME) and adjuvant chemotherapy versus TME followed by adjuvant chemotherapy in very low-lying clinical (c) T3 rectal cancer (NAIR): A multicenter, randomized, open-label, phase 2/3 trial.Org: National Cancer Center Hospital East, Kashiwa, Japan, Division of Gastroenterological Surgery, Saitama Cancer Center, Kurume University School of Medicine, Teikyo University Chiba Medical Center,
Abstract
A randomized controlled trial comparing primary tumor resection plus systemic therapy with systemic therapy alone in metastatic breast cancer (PRIM-BC): Japan Clinical Oncology Group study JCOG1017.Org: Okayama University Hospital, Department of Breast Oncology, Peking University Cancer Hospital, The Cancer Institute Hospital of JFCR, Tokyo, Japan, NHO Shikoku Cancer Center, Gunma Cancer Center,
Abstract
CRES3T: A single-arm confirmatory trial of S-1 plus cisplatin with concurrent radical-dose radiotherapy followed by surgery for superior sulcus tumor.Org: Juntendo University School of Medicine, Department of Surgical Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan, Hiroshima University, National Cancer Center Hospital Japan East, Kashiwa, Japan, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX,
Abstract
A risk prediction model for cisplatin-induced acute kidney injury in head and neck cancer patients who receive chemoradiotherapy: A supplement analysis of a phase II/III trial of JCOG1008.Org: Kobe University Hospital, Kobe, Hyogo, Japan, National Cancer Center Hospital East, Kashiwa, Japan, Kashiwa-Shi, Aichi Cancer Center Hospital, Jichi Medical University Hospital,
Abstract
Effect of lymph node dissection and adjuvant therapy in patients with sentinel node+ melanoma: An observational multicenter study.Org: National Cancer Center Hospital East, Kashiwa, Japan, Tokyo Metropolitan Institute for Geriatrics and Gerontology, Japan Association for Development of Community Medicine, Nagoya University Graduate School of Medicine, Aichi Cancer Center Hospital,